163 related articles for article (PubMed ID: 35691279)
1. Recommendations to Optimize Patient Care in Hidradenitis Suppurativa Clinics: Our Experience.
Boothby-Shoemaker W; Rehman R; Hamzavi I; Huggins RH; Mohammad TF
Dermatology; 2022; 238(6):1104-1107. PubMed ID: 35691279
[No Abstract] [Full Text] [Related]
2. Consensus on the treatment of hidradenitis suppurativa - Brazilian Society of Dermatology.
Magalhães RF; Rivitti-Machado MC; Duarte GV; Souto R; Nunes DH; Chaves M; Hirata SH; Ramos AMC
An Bras Dermatol; 2019 Apr; 94(2 Suppl 1):7-19. PubMed ID: 31166401
[TBL] [Abstract][Full Text] [Related]
3. Hidradenitis suppurativa: Impact of the French guidelines on dermatology practices.
Fottorino A; Richard MA; Prouteau C; Balland C; Villani AP; Buche S; Hotz C; Delage M; Nassif A; Cogrel O; Jouan N
Ann Dermatol Venereol; 2023 Sep; 150(3):227-229. PubMed ID: 36894389
[No Abstract] [Full Text] [Related]
4. Hidradenitis Suppurativa: A Case Study.
Schulman ML; Pantuso HM
J Pediatr Health Care; 2015; 29(4):364-70. PubMed ID: 25575404
[No Abstract] [Full Text] [Related]
5. Development of a clinical Scandinavian registry for hidradenitis suppurativa; HISREG.
Ingvarsson G; Dufour DN; Killasli H; Sartorius K; Lapins J; Skau PA; Moseng D; Dinparvar D; Furberg AS; Jemec GB; Emtestam L
Acta Derm Venereol; 2013 May; 93(3):350-1. PubMed ID: 23093212
[No Abstract] [Full Text] [Related]
6. The Critical Need for Reliable and Clinically Meaningful Outcome Measures for Hidradenitis Suppurativa.
Naik HB
JAMA Dermatol; 2023 Jun; 159(6):581-583. PubMed ID: 37099321
[No Abstract] [Full Text] [Related]
7. Hurley Staging Refined: A Proposal by the Dutch Hidradenitis Suppurativa Expert Group.
Horváth B; Janse IC; Blok JL; Driessen RJ; Boer J; Mekkes JR; Prens EP; van der Zee HH
Acta Derm Venereol; 2017 Mar; 97(3):412-413. PubMed ID: 27535129
[No Abstract] [Full Text] [Related]
8. Surgery is an essential aspect of managing patients with hidradenitis suppurativa.
Melendez Gonzalez MDM; Sayed CJ
J Am Acad Dermatol; 2020 Sep; 83(3):979-980. PubMed ID: 32171813
[No Abstract] [Full Text] [Related]
9. A visit guide for hidradenitis suppurativa-Managing a complex disease in a busy clinic.
Flood KS; Porter ML; Kimball AB
J Am Acad Dermatol; 2021 Mar; 84(3):e155-e160. PubMed ID: 33010310
[No Abstract] [Full Text] [Related]
10. Viewpoint on the Evaluation of Severity and Treatment Effects in Mild Hidradenitis Suppurativa: The Cumulative IHS4.
van der Zee HH; van Huijstee JC; van Straalen KR; Jemec GBE; Zouboulis CC; Tzellos T; Prens EP
Dermatology; 2024; 240(3):514-516. PubMed ID: 38118429
[No Abstract] [Full Text] [Related]
11. Results from the Treatment of Hidradenitis Suppurativa Evaluation Study (THESEUS).
Br J Dermatol; 2024 Feb; 190(3):e33. PubMed ID: 38366828
[No Abstract] [Full Text] [Related]
12. Management of mild hidradenitis suppurativa: our greatest challenge yet.
van der Zee HH; van de Bunte M; van Straalen KR
Br J Dermatol; 2022 Feb; 186(2):355-356. PubMed ID: 34608630
[No Abstract] [Full Text] [Related]
13. Medical therapy is the optimal treatment for hidradenitis suppurativa.
Daveluy S
J Am Acad Dermatol; 2020 Sep; 83(3):977-978. PubMed ID: 32171810
[No Abstract] [Full Text] [Related]
14. Interactive, Proof of Concept Clinical Trial Design in Hidradenitis Suppurativa.
Gottlieb AB
J Invest Dermatol; 2021 Feb; 141(2):431-433. PubMed ID: 32585209
[No Abstract] [Full Text] [Related]
15. The prevalence of metabolic syndrome in patients with hidradenitis suppurativa.
Gold DA; Reeder VJ; Mahan MG; Hamzavi IH
J Am Acad Dermatol; 2014 Apr; 70(4):699-703. PubMed ID: 24433875
[TBL] [Abstract][Full Text] [Related]
16. Proceedings Report of the Fifth Symposium on Hidradenitis Suppurativa Advances (SHSA) 2020.
Schneider C; Adelman M; Almuhanna N; Sakya S; Delorme I; Hamzavi I; Kirby JS
J Drugs Dermatol; 2021 Aug; 20(8):868-873. PubMed ID: 34397198
[TBL] [Abstract][Full Text] [Related]
17. Hidradenitis Suppurativa: A Frequently Missed Diagnosis, Part 2: Treatment Options.
Wang SC; Wang SC; Alavi A; Alhusayen R; Bashash M; Sibbald RG
Adv Skin Wound Care; 2015 Aug; 28(8):372-80; quiz 381-2. PubMed ID: 26181861
[TBL] [Abstract][Full Text] [Related]
18. Hidradenitis suppurativa, a review of pathogenesis, associations and management. Part 1.
Vekic DA; Frew J; Cains GD
Australas J Dermatol; 2018 Nov; 59(4):267-277. PubMed ID: 29355905
[TBL] [Abstract][Full Text] [Related]
19. Negative pressure dressings for severe hidradenitis suppurativa (acne inversa): a case report.
Walls B; Mohammad S; Campbell J; Archer L; Beale J
J Wound Care; 2010 Oct; 19(10):457-60. PubMed ID: 20948495
[TBL] [Abstract][Full Text] [Related]
20. A fatal case of hidradenitis suppurativa associated with sepsis and squamous cell carcinoma.
Verdelli A; Antiga E; Bonciani D; Bonciolini V; Volpi W; Caproni M
Int J Dermatol; 2016 Jan; 55(1):e52-3. PubMed ID: 26475746
[No Abstract] [Full Text] [Related]
[Next] [New Search]
